https://www.selleckchem.com/pr....oducts/pf-04620110.h
Results Among Medicaid-insured women whose infants had in utero substance exposure, 15% received any postpartum SUD treatment. Fewer than half were diagnosed with SUD prenatally. Of those who received postpartum SUD treatment, 68% had received prenatal treatment. No association was observed between postpartum SUD treatment receipt and months of Medicaid enrollment in the year before delivery, prenatal visits, or postpartum visit attendance. Conclusions Most women who likely need postpartum SUD treatment did not receive it and multip
Like
Comment
Share
